Q&As on Surgery: Is Lateral Nodal Dissection Cost Effective in the Surgical Management of Rectal Cancer?

  • Toshiaki Watanabe
  • Soichiro Ishihara
  • Yoshihiro Moriya
Chapter

Abstract

The frequency of lateral pelvic lymph node (LPLN) metastasis in rectal cancer is approximately 15%, and the 5-year overall survival rate of resected LPLN metastasis cases is approximately 40%. Retrospective studies suggest that the prognosis for cases of LPLN metastasis with no distant metastasis may be improved by resection. Whether or not preoperative chemoradiotherapy (CRT) enables the omission of LPLN dissection is a topic under discussion. However, for patients diagnosed as negative for metastasis before CRT, it appears to be reasonable to omit dissection and to then selectively dissect any LPLN diagnosed positive for metastasis.

References

  1. 1.
    Sauer I, Bacon HE (1952) A new approach for excision of carcinoma of the lower portion of the rectum and anal canal. Surg Gynecol Obstet 95(2):229–242PubMedGoogle Scholar
  2. 2.
    Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls RJ, Tekkis P (2009) Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol 10(11):1053–1062. doi: 10.1016/S1470-2045(09)70224-4 CrossRefPubMedGoogle Scholar
  3. 3.
    Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius B, Leer JW, van de Velde CJ (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246(5):693–701. doi: 10.1097/01.sla.0000257358.56863.ce 00000658-200711000-00001 [pii]
  4. 4.
    Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, Untereiner M, Leduc B, Francois E, Maurel J, Seitz JF, Buecher B, Mackiewicz R, Ducreux M, Bedenne L (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24(28):4620–4625. doi: 10.1200/JCO.2006.06.7629 24/28/4620 [pii]
  5. 5.
    Hojo K, Koyama Y (1982) The effectiveness of wide anatomical resection and radical lymphadenectomy for patients with rectal cancer. Jpn J Surg 12(2):111–116CrossRefPubMedGoogle Scholar
  6. 6.
    Hojo K, Koyama Y, Moriya Y (1982) Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg 144(3):350–354CrossRefPubMedGoogle Scholar
  7. 7.
    Moriya Y, Hojo K, Sawada T, Koyama Y (1989) Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum 32(4):307–315CrossRefPubMedGoogle Scholar
  8. 8.
    Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S, Shirouzu K, Muto T (2006) Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 49(11):1663–1672. doi: 10.1007/s10350-006-0714-z CrossRefPubMedGoogle Scholar
  9. 9.
    Kobayashi H, Mochizuki H, Kato T, Mori T, Kameoka S, Shirouzu K, Sugihara K (2009) Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection. Dis Colon Rectum 52(4):567–576. doi: 10.1007/DCR.0b013e3181a1d994 CrossRefPubMedGoogle Scholar
  10. 10.
    Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Fujimori T, Koinuma N, Morita T, Nishimura G, Sakata Y, Takahashi K, Takiuchi H, Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K, Sugihara K (2012) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol 17(1):1–29. doi: 10.1007/s10147-011-0315-2 CrossRefPubMedGoogle Scholar
  11. 11.
    Akiyoshi T, Watanabe T, Miyata S, Kotake K, Muto T, Sugihara K (2012) Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Ann Surg 255(6):1129–1134. doi: 10.1097/SLA.0b013e3182565d9d CrossRefPubMedGoogle Scholar
  12. 12.
    Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J (2004) Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis. Radiology 232(3):773–783. doi: 10.1148/radiol.2323031368 CrossRefPubMedGoogle Scholar
  13. 13.
    Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, Ohue M, Fujii S, Shiozawa M, Yamaguchi T, Moriya Y (2012) Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol 13(6):616–621. doi: 10.1016/s1470-2045(12)70158-4 CrossRefPubMedGoogle Scholar
  14. 14.
    Nagawa H, Muto T, Sunouchi K, Higuchi Y, Tsurita G, Watanabe T, Sawada T (2001) Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 44(9):1274–1280CrossRefPubMedGoogle Scholar
  15. 15.
    Akiyoshi T, Ueno M, Matsueda K, Konishi T, Fujimoto Y, Nagayama S, Fukunaga Y, Unno T, Kano A, Kuroyanagi H, Oya M, Yamaguchi T, Watanabe T, Muto T (2014) Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging. Ann Surg Oncol 21(1):189–196. doi: 10.1245/s10434-013-3216-y CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2018

Authors and Affiliations

  • Toshiaki Watanabe
    • 1
  • Soichiro Ishihara
    • 1
  • Yoshihiro Moriya
    • 2
  1. 1.Department of Surgical OncologyThe University of Tokyo HospitalTokyoJapan
  2. 2.Department of SurgeryJapanese Red Cross Medical CenterTokyoJapan

Personalised recommendations